Immune thrombocytopenia (ITP) trials in South Korea

4 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

  Where

  Busan, Seoul

  Age

  18 years to 64 years

  People

  68 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT06721013 · EU 2024-518502-40-00
• Phase 3Taking people
  A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  Where

  Daegu, Seongnam-si, Seoul

  Age

  18 years and over

  People

  171 worldwide

  Run by

  Takeda

  See details and how to joinNCT06722235 · EU 2024-514401-54-00
• Phase 3Taking people
  A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  Where

  Daegu, Seongnam-si, Seoul

  Age

  18 years and over

  People

  150 worldwide

  Run by

  Takeda

  See details and how to joinNCT06948318 · EU 2025-521692-31-00
• Phase 2Taking people
  The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia

  Where

  Guri-si, Seoul

  Age

  19 years and over

  People

  29

  Run by

  Seoul National University Hospital

  See details and how to joinNCT05599880